SCHEMBL6164948

SCHEMBL6164948

CC1(C)CC(=O)c2c(-c3ccccc3)nn(-c3nc4ccccc4s3)c2C1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 3/20 0.45
NPSR1 Q6W5P4 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPK1 P28482 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
KDM4E B2RXH2 3/20 0.43
SLC11A2 P49281 1/20 0.43
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CRBN Q96SW2 3/20 0.37
HSD17B10 Q99714 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163676 0.94 ALDH1A1 (0.39) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6164039 0.91 APP (0.40) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6164537 0.89 PDE10A (0.48) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6167422 0.88 NPSR1 (0.36) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6166442 0.88 ALDH1A1 (0.36) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6164786 0.88 RAB9A (0.36) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6166322 0.88 LMNA (0.41) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6163663 0.87 ALDH1A1 (0.35) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6163661 0.87 RAB9A (0.41) MAPTALDH1A1SMN1; SMN2TP53NPSR1
SCHEMBL6163911 0.86 MAPT (0.42) MAPTALDH1A1SMN1; SMN2TP53NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed